compound 30 [PMID: 22902653]   Click here for help

GtoPdb Ligand ID: 8118

Compound class: Synthetic organic
Comment: Compound 30 was designed as an inhibitor of the LIM domain kinases LIMK1 and LIMK2 [2]
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 143.05
Molecular weight 503.21
XLogP 2.88
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
Isomeric SMILES CNC(=O)Nc1ncc(s1)c1nc(nc(c1)c1c(C)cc(cc1C)OC(CC)CC)c1nccnc1
InChI InChI=1S/C26H29N7O2S/c1-6-17(7-2)35-18-10-15(3)23(16(4)11-18)20-12-19(22-14-30-26(36-22)33-25(34)27-5)31-24(32-20)21-13-28-8-9-29-21/h8-14,17H,6-7H2,1-5H3,(H2,27,30,33,34)
InChI Key RYXLLTGGHCFCFK-UHFFFAOYSA-N
No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
LIM domain kinases and the related testis-specific protein kinases are known to phosphorylate the actin-binding protein cofilin [1,4,6]. This phosphorylation has an inhibitory effect on cofilin's interaction with F-actin and acts to depolymerise actin, having profound effects on the cytoskeleton [3,5]. LIM kinase inhibitors are being pursued as anti-cancer agents with effects on the invasiveness and metastatic capacity of tumour cells.